Use of metabolic drugs and fish oil in HIV-positive patients with metabolic complications and associations with dyslipidaemia and treatment targets
about
Antiviral drug disposition and natural health products: risk of therapeutic alteration and resistance.Clinical management considerations for dyslipidemia in HIV-infected individuals.Nutrition and the HIV-associated lipodystrophy syndrome.Clinical management of dyslipidaemia associated with combination antiretroviral therapy in HIV-infected patients.
P2860
Use of metabolic drugs and fish oil in HIV-positive patients with metabolic complications and associations with dyslipidaemia and treatment targets
description
article
@en
im September 2007 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2007
@uk
name
Use of metabolic drugs and fis ...... pidaemia and treatment targets
@en
Use of metabolic drugs and fis ...... pidaemia and treatment targets
@nl
type
label
Use of metabolic drugs and fis ...... pidaemia and treatment targets
@en
Use of metabolic drugs and fis ...... pidaemia and treatment targets
@nl
prefLabel
Use of metabolic drugs and fis ...... pidaemia and treatment targets
@en
Use of metabolic drugs and fis ...... pidaemia and treatment targets
@nl
P2093
P2860
P1433
P1476
Use of metabolic drugs and fis ...... pidaemia and treatment targets
@en
P2093
P2860
P304
P356
10.1111/J.1468-1293.2007.00449.X
P577
2007-09-01T00:00:00Z